In the present study, we examined whether lipid infusion-induced insulin resistance in skeletal muscle could be reversed by the antioxidants tempol, glutathione (GSH), or tempol with GSH in male C57BL/6J mice via hyperinsulinemic-euglycemic clamp. Lipid infusion increased the mRNA level of mitochondrial type superoxide dismutase (Mn-SOD), glutathione peroxidase 1, tumor necrosis factor-α, and interleukin-6. Lipid infusion decreased GSH and GSH /glutathione disulfide (GSSG) ratio and increased the activities of JNK and p38 in skeletal muscle. Lipid infusion induced insulin resistance in whole body and skeletal muscle. Treatment with the SOD mimetic tempol did not prevent oxidative stress, the inflammatory response, and insulin resistance induced by lipid infusion. Tempol alone increased oxidative stress and aggravated the lipid-induced inflammatory response. GSH at 100 and 200 μmol ⋅ kg −1 ⋅ h −1 did not prevent insulin resistance and the inflammatory response by lipid infusion. On the contrary, GSH at 100 μmol ⋅ kg −1 ⋅ h −1 with tempol prevented insulin resistance in the whole body and skeletal muscle, and it completely reversed oxidative stress and the inflammatory response. These results suggest that lipid infusion-induced insulin resistance in skeletal muscle is produced by oxidative stress and cotreatment with tempol and GSH inhibits lipid-induced insulin resistance.
Introduction
Insulin resistance, defined as decreases in insulin sensitivity and/or responsiveness to promote glucose disposal in peripheral tissues, plays an important role in the pathogenesis of non-insulin dependent diabetes mellitus (1, 2) .
Many factors have been demonstrated to induce insulin resistance in vivo and in vitro including lipid-derived free fatty acids (FFAs) (3, 4) . In addition to chronic increase of FFAs by a high fat diet, acute and relatively short-term lipid infusion also produces insulin resistance in rodents and humans (5 -8) . Intravenous infusion of 20% intralipid for 2 h induces skeletal muscle insulin resistance (9) . The underlying mechanisms responsible for fatty acid-induced insulin resistance have been investigated for more than forty years since Randle et al. demonstrated that FFAs compete with glucose for oxidative phosphorylation (10) . Recently, however, fatty acid metabolites, oxidative stress, and pro-inflammatory cytokines have received more attention as possible mediators of lipid-induced insulin resistance (11) .
Although the physiological role of reactive oxygen species (ROS) in cellular signaling pathways have been reported, increased production of ROS or/ and reduced capacity of their elimination, termed oxidative stress, induces tissue damage (12, 13) . Previous studies have claimed that acute increase of FFAs by lipid infusion induced oxidative stress and whole body insulin resistance via activation of c-Jun N-terminal kinase (JNK) (6, 14, 15) . Oxidative stress also activates the IκB kinase (IKK) / nuclear factor-κB (NF-κB) system to produce pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), which are also responsible for insulin resistance (15) . However, not all the research agrees with the negative role of ROS in terms of glucose metabolism in skeletal muscle. Indeed, some studies have shown ROS to have a stimulatory effect on glucose uptake under various experimental conditions. Increased ROS generation by muscle contraction stimulates glucose uptake through AMP-activated protein kinase (AMPK) activation in mice (16) . Incubation of isolated muscle with H 2 O 2 increases glucose uptake through a phosphatidylinositol 3-kinase-dependent mechanism (16, 17) .
The first line of defense against ROS-mediated tissue damage comprises several antioxidant enzymes including superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPx) (18, 19) . SOD, including mitochondrial type Mn-SOD and cytosolic type Cu/Zn-SOD, can provide antioxidant protection by inactivating O − 2 , and preventing O − 2 from forming more destructive ROS such as peroxynitrite and ·OH (15, 19) . In skeletal muscle, the mitochondrial respiratory chain continuously produces O − 2 , which is accelerated by the oversupply of FFAs. The generated O − 2 can be converted to less harmful H 2 O 2 by SOD (20) . H 2 O 2 is then scavenged by GPx that converts H 2 O 2 to H 2 O through oxidizing glutathione (GSH) to glutathione disulfide (GSSG) (21, 22) . GSH is then regenerated from GSSG by glutathione reductase (GRx) (23) . Antioxidants such as the SOD mimetic tempol and GSH have been used for the treatment of a variety of diseases (24 -26) .
Therefore, in this study, we investigated whether the SOD mimetic tempol and GSH can reverse acute lipid infusion-induced insulin resistance in skeletal muscle of mice via the hyperinsulinemic-euglycemic clamp technique.
Materials and Methods

Animals
Male C57BL /6J mice were housed in the animal unit of the College of Medicine at Yeungnam University. Mice were housed in a group cage in a room that was on a 12:12-h light/dark cycle, lights-on at 7:00 and lights-off at 19:00. The mice were fed on a standard chow diet and given ad libitum access to water. This study was conducted in accordance with the guidelines for the care and use of laboratory animals provided by Yeungnam University, and all experimental protocols were approved by the ethical committee of Yeungnam University.
Surgery for catheterization
Four days before the experiments, mice were anesthetized by intraperitoneal injection of a combination of anesthetics (25 mg/kg body weight, tiletamine and zolezepam; 10 mg/kg body weight, xylazine), and a catheter (silicone tubing; Helix Medical, Carpinteria, CA, USA) was inserted in the right internal jugular vein. On the day of the experiment, a Y connector was attached to the jugular vein catheter to intravenously deliver solutions (glucose and insulin).
Intravenous infusions
After an overnight fast, mice in the awake state were placed in a rat-size restrainer and tail restrained using a tape to obtain blood samples from the tail vessels. Intralipid (20%) with 33 U/ ml heparin was infused for 2 h before and during the clamp procedure at 3.3 μl /min in the lipid-infused group and saline was infused in the saline-infused group. Intralipid is composed of 20% soybean oil, 1.2% egg yolk phospholipids, 2.25% glycerin, and water (Fresenius Kabi Korea, Cheonan, Korea). Tempol at the rate of 16 μmol ⋅ kg −1 ⋅ min −1 was infused with either the lipid or saline before and during clamp for 4 h. GSH at 100 (GSH100) and 200 (GSH200) μmol ⋅ kg −1 ⋅ h −1 and GSH100 with tempol were infused with the lipid before and during clamp. GSH100 and GSH100 with tempol were infused with saline as a control. For the time-course effect of lipid on inflammation and oxidative stress of skeletal muscle, lipid was infused with 33 U /ml heparin for 0, 0.5, 1, 2, and 3 h at 3.3 μl/min.
Hyperinsulinemic-euglycemic clamp
Hyperinsulinemic euglycemic clamps: For a 2-h hyperinsulinemic euglycemic clamp, human insulin (Novolin; Novo Nordisk, Bagsvaerd, Denmark) was continuously infused at a rate of 15 pmol ⋅ kg −1 ⋅ min −1 to raise plasma insulin. Blood samples (20 μl) were collected by using a capillary tube at 20-min intervals for the immediate measurement of plasma glucose concentration, and 20% glucose was infused at variable rates to maintain glucose at constant concentration. Basal and insulin-stimulated rates of whole body glucose uptake were estimated with a continuous infusion of [3-3 H]glucose (PerkinElmer Life and Analytical Sciences, Waltham, MA, USA) for 2 h before the clamps (0.05 μCi/min) and throughout the clamps (0.1 μCi/min), respectively (27) . To estimate insulin-stimulated glucose uptake in individual tissues, 2-deoxy-D-[1-14 C]glucose (2-[ 14 C]DG, PerkinElmer Life and Analytical Sciences) was administered as a bolus (10 μCi) at 75 min after the start of the clamps (27) . At the end of the clamps, mice were anesthetized, and tissues were dissected and stored at −80°C until biochemical and molecular analysis.
Biochemical assays: Plasma glucose concentration was measured using a Beckman Glucose Analyzer 2 (Beckman, Fullerton, CA, USA), and plasma insulin concentration was measured using enzyme-linked immunosorbent assay (Linco Research, St. Charles, MO, USA). Plasma triglyceride and free fatty acids were determined by enzymatic colorimetric methods (Sigma, St. Louis, MO, USA). Plasma concentrations of [3-3 H]glucose, 2-[ 14 C]DG, and 3 H 2 O were determined after deproteinization of plasma samples (27) . For the determination of tissue 2-[ 14 C]DG 6-phosphate (2-[ 14 C]DG-6-P) content, tissue samples were homogenized, and the supernatants were subjected to an ion exchange column to separate 2-DG-6-P from 2-DG (27) .
Calculations: Rate of insulin-stimulated whole body glucose uptake was determined as the ratio of the [ 3 H]glucose infusion rate [disintegrations per minute (dpm /min)] to the specific activity of plasma glucose (dpm /μmol) during the final 30 min of clamps. Because 2-DG is a glucose analog that is phosphorylated but not metabolized, insulin-stimulated glucose uptake in individual tissues can be estimated by determining the tissue content of 2-[ 14 C]DG-6-P. On this basis, glucose uptake in individual tissues was calculated from the plasma 2-[ 14 C]DG profile, which was fitted with a double exponential or linear curve by using MLAB (Civilized Software, Bethesda, MD, USA) and tissue 2-[ 14 C]DG-6-P content.
Real-time PCR
Skeletal muscle (about 40 mg) was homogenized in TRI reagent (Sigma) using an Ultra-Turrax T25 (Janke & Kunkel, IKA-Labortechnik, Staufel, Germany). RNA was reverse transcribed to cDNA from 1 μg of total RNA by using High-Capacity cDNA Reverse Transcription Kits (Applied Biosystems, Foster City, CA, USA). Quantitative real-time PCR was performed using the Real-Time PCR 7500 Software system and Power SYBR Green PCR master mix (Applied Biosystems), according to the manufacturer's instructions. The reactions were incubated at 95°C for 10 min, followed by 45 cycles at 95°C for 15 s, 55°C for 20 s, and 72°C for 35 s. Expression levels of β-actin were used for sample normalization. Primers for mouse β-actin, TNF-α, IL-6, SOD, and GPx were based on NCBI's Nucleotide database and designed using the Primer Express program (Applied Biosystems): β-actin (121 bp: forward, 5'-TGG ACA GTG AGG CAA GGA TAG-3'; reverse, 5'-TAC TGC CCT GGC TCC TAG CA-3'), TNF-α (71 bp: forward, 5'-CTA TCT CCA GGT TCT CTT CAA-3'; reverse, 5'-GCA GAG AGG AGG TTG ACT TTC), IL-6 (71 bp: forward, 5'-AAA TGA TGG ATG CTA CCA AAC T-3'; reverse, 5'-CCA GAA GAC CAG AGG AAA TTT T-3'), SOD (71 bp: forward, 5'-CTG CTC TAA TCA GGA CCC ATT-3'; reverse, 5'-GTG CTC CCA CAC GTC AAT C-3'), GPx1 (71 bp: forward, 5'-GAA GTG CGA AGT GAA TGG TG-3'; reverse, 5'-TGG GTG TTG GCA AGG C-3').
Western blotting
Skeletal muscle samples were used for measurement of phosphorylated extracellular regulated kinase (pERK), ERK, p-p38, p38, JNK, and p-JNK. Muscles (about 40 mg) were homogenized in a lysis buffer (Invitrogen, Carlsbad, CA, USA) containing 1% NP40, 150 mM NaCl, 5 mM MgCl, 10 mM HEPES, leupeptin, and pepstatin A. A 60-μg sample of the total protein per lane was separated by 12% SDS-polyacrylamide gel electrophoresis. The protein was then transferred to a PVDF membrane (0.45 μm; Gelman Laboratory, Ann Arbor, MI, USA). After blocking with 5% skin milk / 10 mM Tris-HCl, pH 7.4 / 150 mM NaCl / 0.1% Tween 20, the membrane was incubated overnight at 4°C with the primary antibodies (diluted 1:1000). The specific antibody binding was detected using sheep anti-rabbit IgG horseradish peroxidase (1:2000; Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 1 h at room temperature and visualized using an enhanced chemiluminescence detection regent (Amersham Biosciences, Westborough, MA, USA).
GSH and GSH/ GSSG ratio
Total GSH and oxidized GSSG were measured using a Bioxytech GSH /GSSG-412 assay kit (OxisResearch, Foster City, CA, USA). Skeletal muscle (about 50 mg) was diluted 10 times using 50 mM phosphate buffer (pH 7) containing 1 mM EDTA, and homogenized and then centrifuged at 10,000 × g for 15 min (4°C). For oxidized GSSG measurements, 50 μl of the supernatant was mixed with 5 μl of 1-methyl-2-vinylpyridium trifluorlmethanesulfonate (OxisResearch) to prevent GSH oxidation. After the addition of 50 μl of 10% metaphosphoric acid (OxisResearch), the sample mixture was centrifuged at 5000 × g for 5 min. Then, 50 μl of supernatant was mixed with 700 μl of GSSG buffer (OxisResearch) and the assay was performed according to the manufacturer's instructions. For total GSH, 100 μl of supernatant was mixed with 100 μl of 10% metaphosphoric acid and then centrifuged at 5000 × g for 5 min. Then 50 μl of supernatant was mixed with 3 ml of GSH buffer (OxisResearch). The assay was performed according to the manufacturer's instructions. GSH and GSH /GSSG ratio were used as markers for oxidative stress.
Statistics
The results are each expressed as the mean ± S.E.M. The difference between two groups was assessed by Student's t-test and the difference between three or more groups was analyzed by ANOVA with a post-hoc analysis by a Duncan's multiple test. A P value <0.05 was considered significant.
Results
Lipid infusion induced oxidative stress and inflammatory response
In order to determine whether lipid induces oxidative stress, we measured the expression of the antioxidant enzymes Mn-SOD and GPx1 and the markers for oxida-tive stress, GSH and GSH /GSSG ratio, in the skeletal muscle of lipid-infused mice for 0, 0.5, 1, 2, and 3 h. Lipid infusion increased the mRNA expression of Mn-SOD at 0.5 h and GPx1 at 0.5, 1, and 2 h in skeletal muscle (Fig. 1A) . GSH level was decreased by lipid infusion at 0.5, 1, 2, and 3 h; and GSH /GSSG ratio was reduced at 0.5 and 3 h, but showed an increase at 1 h (Fig. 1B) . We speculate that the increased synthesis or activity of antioxidant enzymes temporarily overcomes oxidative stress at the 1-h point of time. Next, the gene expression of pro-inflammatory cytokines and the activities of a mitogen-activated protein kinase (MAPK) subfamily were measured in the skeletal muscle of mice. The mRNA level of TNF-α was increased at 0.5, 1, 2, and 3 h, and the mRNA level of IL-6 was increased at 2 h in lipid infused mice (Fig. 1C) . Activity of the MAPK subfamily was determined by phosphorylation of JNK, p-38, and ERK by Western blotting. While lipid increased the activities of JNK and p-38 in skeletal muscle (Fig. 1D ), ERK was not increased by lipid infusion (data not shown). These results suggest that lipid infusion increases oxidative stress, the inflammatory response, and the activity of MAPK.
Heparin affects lipid metabolism (28) that may influence insulin sensitivity in mice. Therefore, we measured the plasma lipid levels and insulin sensitivity in mice infused with 33 U /ml heparin at 3.3 μl/min, which was the concentration used in lipid-induced insulin resistance experiments. Insulin sensitivity and the plasma levels of triglyceride and free fatty acids were not affected by heparin (data not shown).
Tempol did not prevent oxidative stress and insulin resistance
Initially, we studied the effect of the SOD mimetic tempol on oxidative stress and insulin resistance by lipid infusion. Tempol treatment did not affect plasma concentrations of glucose, insulin, triglycerides, and FFAs. Lipid infusion for 2 h before clamp increased plasma concentrations of triglycerides and FFAs (Table 1 and Fig. 2) .
During clamp experiments, plasma glucose concentration was maintained at approximately 7 mM. Plasma insulin concentrations were significantly higher in both lipid-and lipid with tempol-infused mice compared with saline-infused control mice, although insulin was infused at the same rate in all four groups (Table 1) . Increased insulin levels in lipid-infused mice may be caused by increased endogenous insulin secretion and delayed clearance of insulin in the liver (29) . Insulinstimulated glucose uptake in the whole body and skeletal muscle did not change after tempol infusion, while they were significantly decreased by lipid infusion, suggesting that lipid infusion induces whole body and skeletal muscle insulin resistance. However, coinfusion with lipid and tempol did not prevent insulin resistance (Fig. 2) . Tempol, lipid, or lipid with tempol reduced GSH and the GSH/ GSSG ratio (Fig. 3) . Lipid or lipid with tempol significantly increased the mRNA level of TNF-α and IL-6 ( Fig. 3) . These results suggest that tempol increased oxidative stress rather than decreased it and did not prevent lipid-infused insulin resistance.
GSH with tempol prevented oxidative stress, inflammation, and insulin resistance Next, the effect of cotreatment with GSH and tempol was tested since these two antioxidants have different roles in scavenging ROS. GSH was infused at GSH100 and GSH200. GSH, tempol, or GSH with tempol did not affect plasma concentrations of glucose and insulin in saline-infused or lipid-infused mice compared with the corresponding control mice. Lipid infusion increased plasma concentrations of insulin, although plasma glucose concentrations remained unaltered ( Table 2) . Plasma concentrations of triglyceride and FFAs were markedly increased by lipid infusion, while GSH, tempol, or GSH with tempol did not affect them (Fig. 4) .
Insulin stimulated whole body glucose uptake did not change after treatment with GSH100 or GSH100 and tempol, in the saline-infused group. Lipid infusion significantly reduced insulin stimulated whole body glucose uptake that was reversed by GSH100 with tempol treatment. GSH100 and GSH200 did not prevent lipid-infused insulin resistance. The rate of insulin stimulated glucose uptake in skeletal muscle was significantly reduced by lipid infusion compared with saline-infused control mice. Cotreatment with GSH100 and tempol reversed lipid-infused insulin resistance in skeletal muscle. However, GSH alone did not prevent skeletal muscle insulin resistance (Fig. 4) . These results suggest that cotreatment with GSH100 and tempol prevents whole body and skeletal muscle insulin resistance by lipid infusion.
Cotreatment of mice with GSH and tempol significantly increased the levels of GSH or GSH /GSSG ratio compared with control mice in the lipid-infused group, although neither GSH nor GSH with tempol significantly increased both factors compared with control mice in the saline-infused group (Fig. 5) . The gene expression of TNF-α in skeletal muscle was not significantly changed by either lipid infusion or antioxidants. As we have already shown that lipid infusion increased mRNA expression of TNF-α in the time course study, we speculate that unaltered mRNA levels of TNF-α in this experiment may be caused by a time dependent effect since gene expression was measured at 4 h after lipid infusion. Lipid-infusion significantly increased IL-6 mRNA expression in the skeletal muscle. Cotreatment with GSH100 and tempol reversed the lipidinfused increase in IL-6 mRNA expression, although GSH alone had no effect ( Fig. 5 ). We also measured the activities of the MAPK family but did not find any significant changes (data not shown). Since the phosphorylation of JNK was increased at 0.5 h after lipid infusion that was returned to normal at 1 h (Fig. 1) , it may be hard to detect any changes at 4 h after lipid infusion. Taken together, these results suggest that GSH with tempol prevents insulin resistance, oxidative stress, and the inflammatory response induced by lipid infusion.
Discussion
The present study showed that the lipid infusioninduced oxidative stress and insulin resistance in skeletal muscle was prevented by cotreatment with GSH and tempol. Increased lipid-induced inflammatory response was also reversed by these antioxidants.
In spite of a contradiction as to the role of ROS in glucose metabolism in skeletal muscle, antioxidants have been shown to improve whole body insulin sensitivity and beta cell function. Antioxidant N-acetylcysteine abolished hyperglycemia-induced insulin resistance and attenuated diabetes in Zucker fatty rats due to its effect on preservation of beta cell mass (30) . Infusion of GSH partially prevented lipid-induced whole body insulin resistance (6) . However, few studies have investigated the effect of antioxidants on insulin resistance in skeletal muscle. Here we showed that antioxidants also attenuated skeletal muscle insulin resistance induced by lipid infusion. Our results also support the notion that oxidative stress impairs skeletal muscle insulin resistance. The mitochondrial electron transport chain is the main source of O − 2 in skeletal muscle (31) . The production of O − 2 in mitochondria is regulated by Mn-SOD that converts O − 2 into H 2 O 2 . The importance of Mn-SOD in mitochondria is indicated by the fact that knock-out mice without a gene for Mn-SOD show a lethal phenotype (32) . In spite of the importance of SOD against ROS in mitochondria, however, treatment of mice with the SOD mimetic tempol increased oxidative stress and did not prevent lipid-induced insulin resistance. The prooxidant effect of tempol was also supported by the fact that coinfusion with tempol and lipid exaggerated cytokine expression. Previously it has also been known that SOD mimetics are known to function as either antioxidants or prooxidants depending on the experimental conditions (33) . Tempol treatment induced oxidative stress and impaired mitochondrial function in vascular endothelial and smooth muscle cells (34) , while treatment with tempol in drinking water reduces oxidative stress in obese Zucker rats (35) . The exact mechanism of this prooxidant effect of tempol in our study is not known, but we speculate that increased accumulation of H 2 O 2 may cause oxidative stress. This theory is supported by our finding that cotreatment with tempol and GSH prevented insulin resistance. A previous study also supports our speculation that treatment with tempol increased H 2 O 2 , leading to vasorelaxation in rat mesenteric vessels that was reversed by catalase treatment (36) .
GSH is one of the major antioxidants in cells (37) and reduces free radicals not only by non-enzymatic reactions, but also in conjunction with GPx (38) . A deficiency of GPx induces many detrimental effects in various tissues and animal models (39, 40) . We also showed that acute lipid infusion reduced GSH concentration in skeletal muscles. Furthermore, GSH treatment increased GSH level in skeletal muscle in a dosedependent manner, and oxidative stress by lipid fusion tended to be reversed by GSH treatment. However, GSH did not prevent whole body and skeletal muscle insulin resistance. Inconsistent with our study, GSH was previously observed to prevent whole body insulin resistance induced by 10% lipid-infusion in humans, although skeletal muscle insulin sensitivity was not measured (6) . Currently, the basis of these inconsistent results is unclear, although it is conceivable that the basis may be differences in lipid dosage or experimental species.
In contrast, co-treatment with GSH and tempol effectively reversed lipid-induced oxidative stress and insulin resistance in the whole body and skeletal muscle. As mentioned above, both SOD and GPx are critical scavengers of ROS. Namely, tempol is a scavenger for O − 2 and GSH inactivates H 2 O 2 . Therefore, it seems that the activations of SOD and GPx rather than SOD or GSH alone are an effective way to reverse insulin resistance in skeletal muscle. Consistent with our study, combinations of two antioxidants more effectively reduced oxidative stress than a sole antioxidant in previous studies (41 -43) .
Inflammatory cytokines are expressed not only in adipose tissue but also in skeletal muscle and exert autocrine, paracrine, and endocrine effects (44) . Recent evidences suggest that inflammatory cytokines and signaling pathways are involved in skeletal muscle insulin resistance (45, 46) . Acute elevation of FFAs also increases inflammatory cytokines in skeletal muscle cells and tissues (47, 48) . Consistent with previous studies, the gene expressions of TNF-α and IL-6 increased in the skeletal muscle of lipid-infused mice in our time-course experiment. Furthermore, cotreatment with GSH and tempol inhibited the increase of IL-6 mRNA levels by lipid. These results suggest an inflammatory response might be modulated by oxidative stress.
Overall, lipid-infusion induced insulin resistance in skeletal muscle that was followed by oxidative stress and an increased inflammatory response. While tempol alone functioned as a prooxidant and GSH had no effect on insulin resistance, cotreatment with tempol and GSH inhibited insulin resistance and the inflammatory response by acute lipid infusion. These results suggest that oxidative stress is responsible for insulin resistance in the skeletal muscle of acute lipid-infused mice. Thus, modulation of oxidative stress may provide an effective treatment for acute lipid-induced insulin resistance in skeletal muscle.
